High prevalence of hepatitis C virus type Ib in Italian patients with Porphyria cutanea tarda

Italian Journal of Gastroenterology and Hepatology

Volumn 29, Issue 6, 1997, Pages 543-547

  Sampietro, M ^a,b   Fracanzani, A L ^a   Corbetta, N ^a   Amato, M ^a   Mattioli, M ^b   Molteni, V ^b   Fiorelli, G ^a   Fargion, S ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Hepatitis c; Hepatitis c virus genotypes; Porphyria cutanea tarda

Indexed keywords

ADULT; AGED; ALCOHOL ABUSE; ARTICLE; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; FRANCE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; IRON OVERLOAD; ITALY; MALE; PORPHYRIA CUTANEA TARDA; SPAIN; VIRUS STRAIN;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOLISM; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; DISEASE SUSCEPTIBILITY; GENOTYPE; HEPACIVIRUS; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; IRON OVERLOAD; ITALY; MALE; MIDDLE AGED; ODDS RATIO; PORPHYRIA CUTANEA TARDA; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0031409432     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Cohen PR, Deleo VA. Disorders of porphyrin metabolism. In: Genetic disorders of the skin. Alper JC editor. Chicago: Year Book Medical Publishers 1990;79-104.
2. De Verneuil H, Aitken G, Nordmann Y. Familial and sporadic porphyria cutanea tarda: two different diseases. Hum Genet 1978;44:145-51.
3. Haberman HF, Rosemberg L, Menon LA. Porphyria cutanea tarda: comparison cases precipitated by alcohol and estrogens. Can MedAssocJ 1975; 113:633-55.
4. Felsher BF, Morris ME, Shih JC. Red-cell uroporphyrinogen decarboxylase activity in porphyria cutanea tarda. N Engl J Med 1982;306:766-9.
5. Lundvall O, Weinfeld A, Lundin P. Iron storage in porphyria cutanea tarda. Acta Med Scand 1970;188:37-53.
6. Fargion S, Piperno A, Cappellini MD, Sampietro M, Fracanzani AL, Romano R, et al. Hepatitis C vims and Porphyria Cutanea Tarda: evidence of a strong association. Hepatology 1992; 16:1322-6.
7. Rocchi E, Gibertini P, Cassanelli M, Pietrangelo A, Jensen J, Ventura E. Hepatitis B virus infection in porphyria cutanea tarda. Liver 1986;6:153-7.
8. Wissel PS, Sordilli P. Porphyria cutanea tarda associated svith AIDS. Am J Hematol 1987;25:107-13.
9. Piperno A, D'Alba R, Roffi L, Pozzi M, Farina A, Vecchi L, et al. Hepatitis C virus infection in patients with idiopathic hemochromatosis and porphyria cutanea tarda. Arch Virol 1992;4:215-6.
10. Lefkowitch JK, Grossman ME. Hepatic pathology in porphyria cutanea tarda. Liver 1983;3:19-29.
11. Baravalle E, Prieto J. Serum antibodies against porphyric hepatocytes in patients with porphyria cutanea tarda and liver disease. Gastroenterology 1983;84:1483-91.
12. Lacour JP, Bodokh I, Castanet J, Bekri S, Ortonne JP. Porphyria cutanea tarda and antibodies to hepatitis C virus. Br J Dermatol 1993:128:121-3.
13. Herrero C, Vicente A, Bruguera M, Ercilla MG, Barrera JM, Vidai J, et al. Is Hepatitis C virus infection a trigger of porphyria cutanea tarda? Lancet 1993;341:788-9.
14. Murphy A, Dooley S, Hillary IB, Murpy GM. HCV infection in porphyria cutanea tarda. Lancet 1993;341:1534-5.
15. Stölzel U, Kostler E, Koszka C, Stoffler-Meilicke M, Schuppan D, Somasundaram R, et al. Low prevalence of hepatitis virus infection in Porphyria Cutanea Tarda in Germany. Hepatology 1995;21:1500-3.
16. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994;19:1513-20.
17. Elder GH, Lee OB, Tovey JA. Decreased activity of hepatic uroporphyrinogen decarboxylase in sporadic porphyria cutanea tarda. N Engl J Med 1978;299:274-8.
18. Sampietro M, Salvador! S, Corbetta N, Badalamenti S, Graziani G, Fiorelli G. Single-tube reverse transcription and heminested polymerase chain reaction of hepatitis C virus RNA to detect viremia in serologically negative hemodialysis patients. Int J Clin Lab Res 1995;25:52-4.
19. McOmish F, Yap PL, Dow DC, Follett EAC, Seed C, Keller AJ, et al. Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol 1994;32:884-92.
20. Prati D, Capelli C, Zanella A, Mozzi F, Bosoni P, Pappalettera M, et al. Influence of different hepatitis C virus (HCV) genotypes on the course of asymptomatic HCV infection. Gastroenterology 1996;110:178-83.
21. Silini E, Bono F, Cividini A, Cerino A, Bruno S, Rossi S, et al. Differential distribution of hepatitis C virus genotypes in patients with and without liver fuction abnormalities. Hepatology 1995;21:285-90.
22. Pistello M, Maggi F, Vatteroni L, Cecconi N, Panicucci F, Bresci GP, et al. Prevalence of hepatitis C virus genotypes in Italy. J Clin Microbiol 1994;32:232-4.
23. Pozzato G, Kaneko S, Moretti M, Crocè LS, Franzin F, Unoura M, et al. Different genotypes of Hepatitis C virus are associated with different severity of chronic liver disease. J Med Virol 1994;43:291-6.
24. Dusheiko G, Schmilovitz-Weiss H, Brown D, McOmish F, Yap PL, Sherlock S, et al. Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology 1994:19:13-8.
25. Nousbaum JB, Pol S, Nalpas B, Landais P, Berthelot P, Brechet C. Hepatitis C virus type Ib (II) infection in France and Italy. Ann Intern Med 1995;122:16I-8.
26. Pol S, Thiers V, Nousbaum JB, Legendre C, Berthelot P, Kreis H, et al. The changing relative prevalence of hepatitis C virus genotypes: evidence in hemodialyzed patients and kidney recipients. Gastroenterology 1995;108:581-3.
27. Brudieux E, de Lédinghen V, Oui B, Trimoulet P, Raymond JM, de Verneuil H, et al. Porphyrin metabolism disorders in patients with hepatitis C virus infection. American Association for the Study of Liver Disease. Hepatology 1996;24:150A.
28. Elder GH, Roberts AG. Uroporphyrinogen decarboxylase. J Biomembr Bioenerg 1995;27:207-14.
29. Elder GH, Urquhart AJ, De Salamanca RE, Munoz JJ, Bonkovsky HL. Immunoreactive Uroporphyrinogen decarboxylase in the liver in porphyria cutanea tarda. Lancet 1985; 1:229-32.
30. Fargion S, Fracanzani AL, Romano R, Cappellini MD, Fare M, Mattioli M, et al. Genetic hemochromatosis in Italian patients with porphyria cutanea tarda: possible explanation for iron overload. J Hepatol 1996:24:564-9.
31. Roberts AG, Whatley SD, Morgan RR, Worwood M, Elder GH. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet 1997:349:321-3.
32. Piperno A, Sampietro M, D'Alba R, Roffi L, Fargion S, Parma S, et al. Iron stores, response to alpha-interferon therapy, and effects of iron depletion in chronic hepatitis C. Liver 1996;16:248-54.
33. Hirayama M, Kohgo Y, Kondo H, Shintani N, Fujikawa K, Sasaki K, et al. Regulation of iron metabolism in HepG2 cells: a possible role for cytokines in the hepatic depostion of iron. Hepatology I993;I8:874-80.